Disruptive technology award

Mission statement

ADLM's Disruptive Technology Award Competition (DTAC) aims to evaluate and elevate companies developing new diagnostic tools and technologies that have the potential to improve patient care. DTAC grants the diagnostic and laboratory medicine community an early look at innovative and impactful products that address current gaps in the field and/or improve upon existing solutions.

Learn more about the competition and view past winners.

Congratulations to the 2025 winner

Rarity Bioscience — Rarity superRCA ®

Winner of the 2025 ADLM Disruptive Technology Award and audience choice award.

Learn more about the 2025 winner and competitors.

Questions?

Email [email protected] with any questions about the competition.